Scholarly Index
Dianna M. Milewicz
The University of Texas Health Science Center at Houston; 38,156 total citations; 465 total publications; best world rank #4
The University of Texas Health Science Center at Houston
38,156Total citations
465Total publications
96H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Aortic Disease and Treatment Approaches | Lifetime | 15 | US 9 | 99.84 |
| Connective tissue disorders research | Lifetime | 6 | US 5 | 99.61 |
| Aortic aneurysm repair treatments | Lifetime | 19 | US 11 | 99.70 |
| Cardiac Valve Diseases and Treatments | Lifetime | 412 | US 213 | 99.13 |
| Moyamoya disease diagnosis and treatment | Lifetime | 141 | US 63 | 96.88 |
| Protease and Inhibitor Mechanisms | Lifetime | 784 | US 327 | 95.80 |
| Dermatological and Skeletal Disorders | Lifetime | 442 | US 153 | 92.31 |
| Infectious Aortic and Vascular Conditions | Lifetime | 942 | US 378 | 87.79 |
| Cerebrovascular and genetic disorders | Lifetime | 647 | US 164 | 80.84 |
| Williams Syndrome Research | Lifetime | 310 | US 128 | 76.02 |
| Connective tissue disorders research | 2021-2025 | 4 | US 2 | 98.31 |
| Aortic Disease and Treatment Approaches | 2021-2025 | 40 | US 23 | 98.76 |
| Aortic aneurysm repair treatments | 2021-2025 | 46 | US 21 | 98.24 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 984 | US 339 | 72.63 |
| Moyamoya disease diagnosis and treatment | 2021-2025 | 417 | US 99 | 73.36 |
| Cerebrovascular and genetic disorders | 2021-2025 | 345 | US 50 | 58.11 |